The company focuses on medical dermatology and offers a range of therapeutic solutions for skin conditions such as acne, atopic dermatitis, and scarring. Its key products include Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn, which are used for various skin treatments. Sonoma Pharmaceuticals generates revenue from product sales in multiple countries and aims to improve patient care while reducing healthcare costs by addressing unmet medical needs in wound management, dermatology, women's health, and animal health.